GlaxoSmithKline
GSK
#249
Rank
A$118.32 B
Marketcap
$58.43
Share price
-0.19%
Change (1 day)
-8.30%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.27

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.46. In 2022 the company made an earnings per share (EPS) of $13.24 an increase over its 2021 EPS that were of $4.67.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.27-60.19%
2022$13.24183.39%
2021$4.67-17.83%
2020$5.6921.82%
2019$4.6723.91%
2018$3.77141.48%
2017$1.5664.6%
2016$0.95-90.64%
2015$10.12178.14%
2014$3.64-48.16%
2013$7.0222.63%
2012$5.73-11.32%
2011$6.46230.25%
2010$1.95-70.98%
2009$6.746.76%
2008$6.31-15.14%
2007$7.447.82%
2006$6.9019.61%
2005$5.7718.56%
2004$4.860.36%
2003$4.8550.39%
2002$3.2231.13%
2001$2.46-25.43%
2000$3.3031.58%
1999$2.501.05%
1998$2.48-0.98%
1997$2.50-10.07%
1996$2.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.10-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.90-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.84-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.84 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.96-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.12-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.36-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA